Agency News from Centron, Jocoto and Harrison and Star

Share this article:
Centron won the agency of record assignment for Cephalon's AMRIX capsules as well as the medical education agency assignment for a new product being developed by Acorda Therapeutics.

Jocoto said it has won launch assignments from Abaxis' animal health unit, IntraPace, Luminous Medical, Relievant Medical and a minimally invasive back surgery company. The San Francisco-based medical agency said it has seen a 25%-30% increase in spend since the economic downturn began in 2009.

Harrison and Star was named agency of record for the launch of Incyte's Janus-Associated Kinase inhibitor currently known as INCB18424, a first-in-class compound that, if approved, could become the first drug indicated for myleofibrosis.

Share this article:
You must be a registered member of MMM to post a comment.

Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.